Genetic Analysis Implicates Dysregulation of SHANK2 in Renal Cell Carcinoma Progression
Open Access
- 30 September 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (19) , 12471
Abstract
SH3 and multiple ankyrin repeat domains (SHANK) is a family of scaffold proteins that were first identified to be involved in balancing synaptic transmission via regulation of intracellular signalling crosstalk and have been linked to various cancers. However, the role of the SHANK genes in renal cell carcinoma (RCC) remains to be elucidated. In this study, we aimed to evaluate whether genetic variants in SHANK family genes affect the risk of RCC and survival of patients. A genetic association study was conducted using logistic regression and Cox regression analyses, followed by the correction for a false discovery rate (FDR), in 630 patients with RCC and controls. A pooled analysis was further performed to summarise the clinical relevance of SHANK gene expression in RCC. After adjustment for known risk factors and the FDR, the SHANK2 rs10792565 T allele was found to be associated with an increased risk of RCC (adjusted odds ratio = 1.79, 95% confidence interval = 1.32–2.44, p = 1.96 × 10−4, q = 0.030), whereas no significant association was found with RCC survival. A pooled analysis of 19 independent studies, comprising 1509 RCC and 414 adjacent normal tissues, showed that the expression of SHANK2 was significantly lower in RCC than in normal tissues (p < 0.001). Furthermore, low expression of SHANK2 was correlated with an advanced stage and poor prognosis for patients with clear cell and papillary RCC. This study suggests that SHANK2 rs10792565 is associated with an increased risk of RCC and that SHANK2 may play a role in RCC progression.Keywords
Funding Information
- the Ministry of Science and Technology of Taiwan (106-2314-B-002-235-MY3, 108-2314-B-037-029, 108-2314-B-037-026-MY2, 108-2320-B-039-050-MY3, 109-2314-B-037-108-MY2, 109-2314-B-037-106-MY3, 109-2320-B-037-007-MY3, 111-2320-B-039-021-MY3, KMUH105-5R42, KMUH108-8R53, KMUH108-8R55, KMUH109-9R63, KMUH109-9R64, KMU-TC108A04-4, CMU109-S-46, CMU109-SR-64, CMU109-MF-65, CMU110-MF-59, CMU111-MF-09)
- the Kaohsiung Medical University Hospital (106-2314-B-002-235-MY3, 108-2314-B-037-029, 108-2314-B-037-026-MY2, 108-2320-B-039-050-MY3, 109-2314-B-037-108-MY2, 109-2314-B-037-106-MY3, 109-2320-B-037-007-MY3, 111-2320-B-039-021-MY3, KMUH105-5R42, KMUH108-8R53, KMUH108-8R55, KMUH109-9R63, KMUH109-9R64, KMU-TC108A04-4, CMU109-S-46, CMU109-SR-64, CMU109-MF-65, CMU110-MF-59, CMU111-MF-09)
- The Kaohsiung Medical University Research Center (106-2314-B-002-235-MY3, 108-2314-B-037-029, 108-2314-B-037-026-MY2, 108-2320-B-039-050-MY3, 109-2314-B-037-108-MY2, 109-2314-B-037-106-MY3, 109-2320-B-037-007-MY3, 111-2320-B-039-021-MY3, KMUH105-5R42, KMUH108-8R53, KMUH108-8R55, KMUH109-9R63, KMUH109-9R64, KMU-TC108A04-4, CMU109-S-46, CMU109-SR-64, CMU109-MF-65, CMU110-MF-59, CMU111-MF-09)
- the China Medical University (106-2314-B-002-235-MY3, 108-2314-B-037-029, 108-2314-B-037-026-MY2, 108-2320-B-039-050-MY3, 109-2314-B-037-108-MY2, 109-2314-B-037-106-MY3, 109-2320-B-037-007-MY3, 111-2320-B-039-021-MY3, KMUH105-5R42, KMUH108-8R53, KMUH108-8R55, KMUH109-9R63, KMUH109-9R64, KMU-TC108A04-4, CMU109-S-46, CMU109-SR-64, CMU109-MF-65, CMU110-MF-59, CMU111-MF-09)
This publication has 33 references indexed in Scilit:
- Transcriptome and genome sequencing uncovers functional variation in humansNature, 2013
- The Genotype-Tissue Expression (GTEx) projectNature Genetics, 2013
- Stratifying Risk of Urinary Tract Malignant Tumors in Patients With Asymptomatic Microscopic HematuriaMayo Clinic Proceedings, 2013
- An integrated map of genetic variation from 1,092 human genomesNature, 2012
- The polymorphisms of P53 codon 72 and MDM2 SNP309 and renal cell carcinoma risk in a low arsenic exposure areaToxicology and Applied Pharmacology, 2011
- Newly identified tumor-associated role of human SharpinMolecular and Cellular Biochemistry, 2010
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008
- Statistical significance for genomewide studiesProceedings of the National Academy of Sciences, 2003
- Sharpin, a Novel Postsynaptic Density Protein That Directly Interacts with the Shank Family of ProteinsMolecular and Cellular Neuroscience, 2001
- Rising Incidence of Renal Cell Cancer in the United StatesJAMA, 1999